annual CFI:
-$62.85M-$62.82M(-261766.67%)Summary
- As of today (May 29, 2025), NAMS annual cash flow from investing activities is -$62.85 million, with the most recent change of -$62.82 million (-261766.67%) on December 31, 2024.
- During the last 3 years, NAMS annual CFI has fallen by -$62.82 million (-261766.67%).
- NAMS annual CFI is now -392700.00% below its all-time high of -$16.00 thousand, reached on December 1, 2020.
Performance
NAMS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$2.85M+$65.03M(+104.59%)Summary
- As of today (May 29, 2025), NAMS quarterly cash flow from investing activities is $2.85 million, with the most recent change of +$65.03 million (+104.59%) on March 31, 2025.
- Over the past year, NAMS quarterly CFI has increased by +$3.24 million (+841.56%).
- NAMS quarterly CFI is now at all-time high.
Performance
NAMS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$59.61M+$3.24M(+5.16%)Summary
- As of today (May 29, 2025), NAMS TTM cash flow from investing activities is -$59.61 million, with the most recent change of +$3.24 million (+5.16%) on March 31, 2025.
- Over the past year, NAMS TTM CFI has dropped by -$59.21 million (-14727.86%).
- NAMS TTM CFI is now -851442.86% below its all-time high of -$7000.00, reached on March 31, 2023.
Performance
NAMS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NAMS Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -10000.0% | +841.6% | -10000.0% |
3 y3 years | -10000.0% | - | - |
5 y5 years | -10000.0% | - | - |
NAMS Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | <-9999.0% | at low | at high | +104.6% | <-9999.0% | +5.2% |
5 y | 5-year | <-9999.0% | at low | at high | +104.6% | <-9999.0% | +5.2% |
alltime | all time | <-9999.0% | at low | at high | +104.6% | <-9999.0% | +5.2% |
NAMS Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $2.85M(-104.6%) | -$59.61M(-5.2%) |
Dec 2024 | -$62.85M(>+9900.0%) | -$62.18M(>+9900.0%) | -$62.85M(+9252.4%) |
Sep 2024 | - | -$75.00K(-64.1%) | -$672.00K(+10.9%) |
Jun 2024 | - | -$209.00K(-45.7%) | -$606.00K(+50.7%) |
Mar 2024 | - | -$385.00K(>+9900.0%) | -$402.00K(+1575.0%) |
Dec 2023 | -$24.00K | -$3000.00(-66.7%) | -$24.00K(+14.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | -$9000.00(+80.0%) | -$21.00K(+75.0%) |
Jun 2023 | - | -$5000.00(-28.6%) | -$12.00K(+71.4%) |
Mar 2023 | - | -$7000.00 | -$7000.00 |
Dec 2022 | -$221.00K(+820.8%) | - | - |
Dec 2021 | -$24.00K(+50.0%) | - | - |
Dec 2020 | -$16.00K | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?
- What is the all time high annual CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?
What is NewAmsterdam Pharma Company NV annual cash flow from investing activities?
The current annual CFI of NAMS is -$62.85M
What is the all time high annual CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual cash flow from investing activities is -$16.00K
What is NewAmsterdam Pharma Company NV annual CFI year-on-year change?
Over the past year, NAMS annual cash flow from investing activities has changed by -$62.82M (-261766.67%)
What is NewAmsterdam Pharma Company NV quarterly cash flow from investing activities?
The current quarterly CFI of NAMS is $2.85M
What is the all time high quarterly CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly cash flow from investing activities is $2.85M
What is NewAmsterdam Pharma Company NV quarterly CFI year-on-year change?
Over the past year, NAMS quarterly cash flow from investing activities has changed by +$3.24M (+841.56%)
What is NewAmsterdam Pharma Company NV TTM cash flow from investing activities?
The current TTM CFI of NAMS is -$59.61M
What is the all time high TTM CFI for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM cash flow from investing activities is -$7000.00
What is NewAmsterdam Pharma Company NV TTM CFI year-on-year change?
Over the past year, NAMS TTM cash flow from investing activities has changed by -$59.21M (-14727.86%)